Paracetamol, 50 Other Drug Samples Fail Quality Test. See Full List

22 of these substandard drugs were manufactured in Himachal Pradesh (representational)
The Central Drugs Standard Control Organisation (CDSCO) has raised concerns over the quality of 51 drug samples, including popular medications like paracetamol, pantoprazole and various antibiotics used to treat bacterial infections.
In a report released on June 20, CDSCO, India’s drugs regulatory body, said 22 of these substandard drugs were manufactured in Himachal Pradesh. The other samples were collected from Jaipur, Hyderabad, Waghodia, Vadodara, Andhra Pradesh and Indore.
Full list of drugs that failed quality tests:Cyra Tablets, Rabeprazole Sodium Tablets IPRabedin tablet Tablets, Rabeprazole Sodium GastroResistant Tablets IPMoxtas Distab 250 Tablets, Amoxycillin trihydrate dispersible tablets IPTolcenta-P Tablets, Tolperisone Hydrochloride and Paracetamol tabletsNagris Pakeezah Art Henna Oxifer-XT Tablets, Ferrous ascorbate elemental iron, Folic acid and Zinc sulphate TabletsLevolets- M Kid Syrups, Montelukast Sodium & Levocetirizine Dihydrochloride syrup Meazon Plus injection Parentaral Preparations, Mecobalamine, Folic acid & Niacianamideinj 1 mlXeronac-SP Tablets, Aceclofenac, Paracetamol and Serratiopeptidas e TabletsPedxim-200 Tablets, Cefpodoximepro xetil Tablets 200 mg DofloxOZT Tablets, Ofloxacin&Ornid azole Tablets Disinfectants, Surgical Spirit BP Sif Alben Suspension, Albendazole Oral Suspension 2.5% w/v (Vet)Terbutaline Sulfate,Bromhexin e Hydrochloride with Guaiphenesin SyrupMetoprolol Succinate Extended Release Tablets IPCuftin Cough Linctus CefuroximeAxetil Tablets IP LevosalbutamolSul phate,AmbroxolHC L,Guaiphenesin SyrupAcetylsalicylic Acid Tablets 75 mgLactuloseSolution U.S.P.Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesinand Menthol SyrupPrednisolone Tablets IP10mgMecobalamin, AlphaLipoicAcid, Pyridoxine Hydrochlorideand Folic Acid Soft Gelatin CapsulesTelmisartan Andamlodipine Tablets IP Cefoperazone& Sulbactam for Injection Cefotaxime InjectionIP500mgDexamethasone SodiumPhosphate Injection I.PAmoxycillin&Potas sium Clavulanate InjectionIP1.2gmTelmisartan and Metoprolol Succinate (Extended Release) TabletsPantoprazole Tablets IP.Ambroxol HCl, Levosalbutamoland Guaiphenesin Syrup Dexamethasone Sodium Phosphate Injection I.P. (8mg/2ml)Dexamethasone Sodiumphosphate Injection IP Paracetamol 500 mg. TabletsOfloxacin Ornidazole Tablets IP Vildagliptinand Metformin Hydrochloride Tablets IP 50mg/1000mgAmoxycillin and Potassium Clavulanate Tablets I.P.Clonazepam TabletsI.P.0.5mgMetronidazole Extended Release Tablets USP 600 MGDiclofenac Sodium and Paracetamol Tablets IP Atropine Sulphate Injection IP Montelukast Sodium and Levocetirizine Hydrochloride TabletsFluconazole Tablets IP (150 mg)Ceftriaxone Injection IP Ramipril and Hydrochlorthiazide Tablets IPGlipizideand Metformin Tablets IPCeftriaxone for InjectionI.P.1gmGentamicin Sulphate Injection I.P. 2ml Calcium 500 mg with Vitamin D3250 IU Tablets IPCefixime and Ofloxacin TabletsCeftriaxone Injection IP
The drug regulator has issued notices to the pharmaceutical companies manufacturing these medicines, news agency PTI reported. The failed samples will also be recalled from the market.
The list of 51 drugs that failed the quality test is significantly smaller compared to last year’s 120. These samples, manufactured in Himachal Pradesh, had also failed quality tests.